Sheree Bryant

3.9K posts

Sheree Bryant banner
Sheree Bryant

Sheree Bryant

@SQueenBryant

Fast walker. Audiophile. Optimist. Reader, writer, thinker & doer. Lapsed Texan. Director & trustee. Global health & ed strategy & comms 🇺🇸🇬🇧🇪🇺 #kindness

At the beach 🌏 Katılım Ocak 2010
4.1K Takip Edilen1.2K Takipçiler
Sheree Bryant
Sheree Bryant@SQueenBryant·
Ihtesham Ali@ihtesham2005

🚨BREAKING: Stanford and Microsoft just built an AI scientist that writes medical research papers that actually pass peer review. Not summaries. Not drafts. Full papers reviewed and accepted by real scientists. This is not a demo and this is not a prototype. A peer-reviewed conference just accepted a paper that no human wrote, and most people have absolutely no idea it happened. The system is called Medical AI Scientist and it works in three stages that run completely on their own. First, it reads medical literature, identifies real clinical gaps, and generates a research hypothesis grounded in actual disease evidence, not a hallucination and not a generic idea pulled from thin air. Then it writes the code, runs the experiment inside a secure environment, catches its own errors, and fixes them without any human stepping in. Then it writes the full paper, including the introduction, methods, results, figures, ethics statement, citations, and LaTeX formatting, from start to finish, autonomously. They tested it against GPT-5 and Gemini 2.5 Pro across 171 real medical research cases covering 19 clinical tasks, and the results were not close. Medical AI Scientist successfully completed experiments 91 to 93 percent of the time. GPT-5 managed 60 to 75 percent. Gemini 2.5 Pro collapsed somewhere between 40 and 53 percent. Then they ran the part that genuinely broke my brain. Ten independent medical experts with over five years of first-author publishing experience reviewed the AI-generated papers side by side with real human papers from MICCAI, ISBI, and BIBM, the top conferences in medical imaging, and nobody knew which was which. The AI papers scored competitively on novelty, clarity, coherence, and reproducibility across the board, and one paper was accepted at a peer-reviewed conference after a full review process. Here is what nobody is saying out loud. Medical research has a brutal bottleneck where ideas pile up, experiments take months, papers take even longer, and patients wait the entire time. That problem just got a serious solution, and the implications for healthcare are enormous.

English
0
0
0
63
Sheree Bryant retweetledi
EASO
EASO@EASOobesity·
📢The EASO Algorithm for the pharmacological treatment of obesity and its complications has been published in @NatureMedicine Developed using rigorous analysis, it provides clinically relevant guidance for personalised medication management. nature.com/articles/s4159… @busetto_luca
EASO tweet media
English
2
15
26
7.1K
Sheree Bryant retweetledi
EASO
EASO@EASOobesity·
EASO ECN Exchange Programme - Applications Now Open! Participants will gain insight into working within a research centre by: ✅ Attending team meetings and touring the host facilities ✅ Engaging in discussion, research and collaboration with experts easo.org/easo-ecn-excha…
EASO tweet media
English
0
1
3
246
Sheree Bryant retweetledi
Sheree Bryant retweetledi
EASO
EASO@EASOobesity·
It’s Day 3 of #ECO2025! We have a number of standout sessions today, including the @EASOobesity Framework and Algorithm session in Auditorium 1 at 9.30! Read the newsletter to catch up and preview the day ahead mailchi.mp/e99896291f21/e…
EASO tweet media
English
0
3
10
1.5K
Sheree Bryant
Sheree Bryant@SQueenBryant·
Michael Albert, MD@MichaelAlbertMD

🚨 New data drop: GLP-1s are shrinking more than waistlines—they're reshaping the grocery cart. - - - A large consumer survey (n=1955) just revealed how GLP-1 meds like Wegovy and Zepbound are disrupting diets—and potentially the entire food industry. ⬇️ Key survey takeaways 🔹Average reduction in reported intake while on a GLP-1: –700 to –990 kcal/day 🔹 Biggest cut‑backs: processed foods (‑70 %), sugary drinks (‑50%), refined grains & beef (-50%) 🔹 Biggest upticks: leafy greens (+30%), fruit (+15%), plain water (+60 %) The plot twist: Cravings for high‑calorie treats stay high—even as forks stay down. Early mechanistic work suggests GLP‑1 therapy: ▪️ Turns up sweet‑taste sensitivity 🧠👅 ▪️ Turns down the dopamine “yum” for fatty foods 🍟➡️😐 ▪️ Rewires brain‑gut circuits, breaking the usual want → eat loop 📊 Demographics matter: Women, those with higher education and income, and larger households were more likely to be current or future GLP-1 users. Why it matters 🧠 Takeaway: These meds don’t just suppress appetite—they subtly rewire preferences. That has massive implications for food marketers, clinicians, and public health efforts. Source: sciencedirect.com/science/articl… #Obesity #GLP1 #Ozempic #Wegovy #Zepbound #NutritionScience #FoodTrends #Metabolism

English
0
0
1
59
Sheree Bryant retweetledi
ECPO
ECPO@ECPObesity·
📢 Did you know? Obesity is a major driver of serious health conditions: 🔹 44% of Type 2 diabetes 🔹 23% of ischaemic heart disease 🔹 7–41% of certain cancers Yet, many patients aren’t aware of these links. Knowledge is power—understanding these risks can help people take action and seek support sooner! 💡 Let’s raise awareness and empower change. #AddressingObesityTogether #WODEurope
ECPO tweet media
English
0
5
8
189
Sheree Bryant retweetledi
ECPO
ECPO@ECPObesity·
We’re sharing an important survey exploring thoughts and attitudes about obesity communication. 📋 What’s it about? This survey seeks to understand the challenges individuals and groups face with how obesity is communicated to different audiences. The insights gathered will help shape a project aimed at collecting examples of obesity communications and developing solutions to address these challenges. 💡 Why participate? Your thoughts matter. There are no right or wrong answers—we’re simply interested in your perspectives at this stage. Together, we can make a meaningful impact on how obesity is understood and discussed. 👉 Take the survey here: leedspsychology.eu.qualtrics.com/jfe/form/SV_br… #AddressingObesityTogether leedspsychology.eu.qualtrics.com/jfe/form/SV_br…
English
0
4
8
441
Sheree Bryant retweetledi
EASO
EASO@EASOobesity·
📢 EASO has raised significant concerns about the recent Lancet Commission report on the definition and diagnostic criteria of clinical obesity, highlighting potential risks to obesity management and patient care. Read more here: easo.org/easo-response-… @EASOobesityECN
EASO tweet media
English
0
5
14
1.6K